Søren Jensen active positions
Companies | Position | Start | End |
---|---|---|---|
Tecleaf ApS | Chairman | - | - |
Samfonden | Director/Board Member | - | - |
Fulton Foundation | Director/Board Member | - | - |
Career history of Søren Jensen
Former positions of Søren Jensen
Companies | Position | Start | End |
---|---|---|---|
ALLARITY THERAPEUTICS, INC. | Director/Board Member | 31/07/2021 | 04/02/2023 |
Independent Dir/Board Member | 31/07/2021 | 04/02/2023 | |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Director/Board Member | 01/09/2020 | - |
Independent Dir/Board Member | 01/09/2020 | - |
Training of Søren Jensen
University of Aarhus | Graduate Degree |
Statistics
International
Denmark | 5 |
United States | 3 |
Operational
Director/Board Member | 4 |
Independent Dir/Board Member | 2 |
Chairman | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
ALLARITY THERAPEUTICS, INC. | Health Technology |
Private companies | 4 |
---|---|
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Health Technology |
Tecleaf ApS | |
Samfonden | |
Fulton Foundation |
- Stock Market
- Insiders
- Søren Jensen
- Experience